News

The National Institute for Health and Care Excellence1d
Final draft guidance finds benefits of 2 Alzheimer’s treatments remain too small to justify the additional costs to the NHS
The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs ...
The National Institute for Health and Care Excellence4d
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.